BIANA MILLER: Open Payments
NPI 1285805077 · LAWRENCE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 61 payments from 17 companies in 2025. Trend: 2023 $1,312 · 2024 $1,331 · 2025 $1,542
Food & beverage: $1,542
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $548 |
| ABBVIE INC. | 19 | $392 |
| Lilly USA, LLC | 8 | $145 |
| Phathom Pharmaceuticals, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $42 |
| Novo Nordisk Inc | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $36 |
| Astellas Pharma US Inc | 2 | $34 |
| Renalytix AI, Inc. | 2 | $34 |
Products named: FARXIGA, QULIPTA, MOUNJARO, BREZTRI, VRAYLAR, VOQUEZNA, UBRELVY, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
